JSPR News

Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

Lifshitz Law PLLC Announces Investigations of Fly-E Group, Inc. (NASDAQ:FLYE), Jasper Therapeutics, Inc. (NASDAQ:JSPR), RCI Hospitality Holdings, Inc. (NASDAQ:RICK), And Molina Healthcare, Inc. (NYSE:MOH)

JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit

JSPR DEADLINE - FINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Jasper Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit

Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Pomerantz LLP Reports Filing of Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR

JSPR DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Jasper Therapeutics, Inc. Investors to Join the Class Action Lawsuit

Pomerantz LLP Reports Filing of Class Action Against Jasper Therapeutics, Inc. – JSPR